AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Amarillo Biosciences Receives Grant To Develop H. pylori Vaccine.(Brief Article)
2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc. has received a Small Business Innovative Research (SBIR) grant from the U.S. National Institutes of Health (NIH) for $96,248 to be used to develop a vaccine to combat Helicobacter pylori, a major cause of gastric cancer.
Amarillo Biosciences will collaborate with Steven Krakowka, DVM, PhD, of the Ohio State University and John Ellis, DVM, PhD, of Capricorn Research and Development, Laramie, Wyoming.
H. pylori is a spiral-shaped bacterium that is found in the stomach of humans in which it causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers. Approximately two-thirds of the world's human population is infected with H. pylori.
In developing countries, infection is frequently symptomatic and is responsible for the high incidence of gastric cancer. The cost and expense of pharmacological intervention is beyond the means of most of the population. ...
- Amarillo Biosciences Requests Designated New Animal Drug Listing for Ten...
- Press release article from: PR Newswire September 9, 2004 700+ words
...Conduct Studies on Approved Listings Amarillo Biosciences, Inc. (BULLETIN BOARD: AMAR...grants that it will be seeking, Amarillo Biosciences intends to fund a number of studies...successful outcome of these studies, Amarillo Biosciences would be able to commence marketing...
- Amarillo Biosciences' Technology Receives Additional Scientific Validation;...
- Press release article from: PR Newswire October 23, 1997 700+ words
...Texas, Oct. 23 /PRNewswire/ -- Amarillo Biosciences Inc. (Nasdaq: AMAR) today announced...variety of medical conditions. Amarillo Biosciences' technology platform involves the...Cummins, president and CEO of Amarillo Biosciences. "We hope that data from this...
- Amarillo Biosciences Moves Toward Phase III Trial; Contracts With PPD Pharmaco...
- Press release article from: PR Newswire July 14, 1997 700+ words
...Texas, July 14 /PRNewswire/ -- Amarillo Biosciences Inc. (Nasdaq: AMAR) today announced...research organization, to conduct Amarillo Biosciences' Phase III clinical trial testing...Sjogren's Syndrome Foundation. Amarillo Biosciences expects to complete its Phase II...
- Amarillo Biosciences Reports New Patent Issues in United States
- Press release article from: PR Newswire April 14, 1998 700+ words
...Texas, April 14 /PRNewswire/ -- Amarillo Biosciences Inc. (Nasdaq: AMAR) today announced...of patents owned or licensed by Amarillo Biosciences to 15 with eight U.S. patent...Cummins, president and CEO of Amarillo Biosciences. "This strategy will benefit the...
- Amarillo Biosciences (ABI) President Dr. Joseph M. Cummins to Address Japan...
- Press release article from: PR Newswire June 24, 2004 700+ words
...Joseph M. Cummins, President and CEO of Amarillo Biosciences Inc. (BULLETIN BOARD: AMAR) (ABI...better way to respond to FMD." About Amarillo Biosciences, Inc. Amarillo Biosciences, Inc., is a U.S. biotechnology...
- Amarillo Biosciences's Orally-Administered Interferon Alpha to Be Tested As...
- Press release article from: PR Newswire November 7, 2001 700+ words
...Texas, Nov. 7 /PRNewswire/ -- Amarillo Biosciences, Inc. (OTC Bulletin Board: AMAR...study of 20 patients with IPF. Amarillo Biosciences will collaborate on this research...Cummins, President and CEO of Amarillo Biosciences, Inc. said, "This is a very...
- Amarillo Biosciences Reports Positive Phase II Sjogren's Syndrome Study Data
- Press release article from: PR Newswire December 1, 1997 700+ words
...Texas, Dec. 1 /PRNewswire/ -- Amarillo Biosciences Inc. (Nasdaq: AMAR) today announced...Cummins, President and CEO of Amarillo Biosciences. "The purpose of a Phase II clinical...Company to file for FDA approval. Amarillo Biosciences, founded in 1984, is one of the...
- Amarillo Biosciences Signs Letter of Intent with Agritek Bio Ingredients...
- Press release article from: PR Newswire November 9, 1998 700+ words
...Texas, Nov. 9 /PRNewswire/ -- Amarillo Biosciences Inc. (Nasdaq: AMAR) today announced...a wholly-owned subsidiary of Amarillo Biosciences, holds the rights to animal patents...payments of up to US $2.0 million to Amarillo Biosciences and to obtain FDA approvals. The...
Source: HighBeam Research, Amarillo Biosciences Receives Grant To Develop H. pylori...